Research in CAMH’s Geriatric Psychiatry Division focuses on the etiology, assessment, treatment, rehabilitation, and prevention of mental disorders and addiction in late life. Building on strong clinical services, the development of a strong and focused research program is critical for our mission to improve the care of older persons with mental illness and addiction in Ontario.
We work in partnership with CAMH scientific and clinical staff, and with locally, nationally internationally recognized neuroscientists and clinical scientists to study ways to improve care for older people with mental disorders such as major depression, bipolar disorder, schizophrenia, or dementia (Alzheimer Disease).
Impact on client care
The aim of our current work is to improve our understanding of treatment mechanisms and differences in individuals’ response to treatment, so that we can ultimately improve and personalize care with medication, psychotherapy, or brain stimulation. The result will be enhanced efficacy and fewer adverse experiences related to these treatments for late-life mental disorders.
Research approaches
Brain therapeutics
Genetics
Neuroimaging
Neurophysiology
Neuropsychology
Pharmacology
Current projects
The Geriatric Psychiatry Division at CAMH is conducting several studies to improve the outcomes of late-life mental disorders. Visit our
Find a CAMH Study search tool to find more details on the following studies:
- Cognition in Euthymic Older Adults with Bipolar Disorders
Late- Life Schizophrenia Studies
- A Diffusion Tensor Imaging and Genetics Study of Psychosis Across the Lifespan
- Cognition in Older Adults with Late-Life Schizophrenia and Related Disorders
- Cognitive Behavioural Social Skills Training (CBSST) for Patients with Late- Life Schizophrenia
- Incomplete Response in Late Life Depression: Getting to Remission (IRL-GRey)
- Sustaining Remission of psychotic Depression (STOP-PD II)
- Effects of Maintenance Treatment with Olanzapine vs. Placebo on Brain Structure
Dementia Studies
- Citalopram for Agitation in Alzheimer’s disease (CITAD): A Multicenter Clinical Trial
- Relation of Beta-Amyloid to Psychiatric Disturbances in Dementia
Researchers
Dielle Miranda
Dr. Daniel. Blumberger
Dr. Tiffany Chow
Dr. Vincenzo DeLuca
Dr. Phil. Gerretsen
Dr. Ariel Graff
Dr. Benoit Mulsant
Dr. Bruce Pollock
Dr. Aristotle Voineskos